Sort
82,697 grants matching “vaccine development”
P1 - COMBINATION ACTIVATED T-CELL AND VACCINE THERAPY IN MYELOMA
$959,257Larry W Kwak · University Of Tx Md Anderson Can Ctr · P50 · FY2012 · CA
Inducing HIV-1 NAb Breadth by Native Trimer Prime-Boost Vaccination
$959,144James M Binley · San Diego Biomedical Research Institute · R01 · FY2020 · AI
IDENTIFYING NOVEL VIRUSES IN HUMAN MALIGNANCY
$959,058Nathan D Wolfe · Metabiota, Inc · RC2 · FY2009 · CA
Molecular Basis of KSHV oncogenesis
$958,770Jae U Jung · University Of Southern California · R35 · FY2017 · CA
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
$958,744Toni Darville · Univ Of North Carolina Chapel Hill · U19 · FY2021 · AI
Development Of Vaccines For Genital Herpes Simplex Infection
$958,430Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Influenza and Emerging Infectious Diseases
$958,408Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Core A: Protein Sciences
$958,363Neil King · University Of Washington · P01 · FY2022 · AI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$958,345Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2024 · AI
Cooperative Center for the study of HCV antibody responses and vaccine antigens
$958,342Mansun Law · Scripps Research Institute, The · U19 · FY2016 · AI
Global HIV/AIDS Vaccine Enterprise
$958,333National Institute Of Allergy And Infectious Diseases · Y01 · FY2017 · AI
Global HIV/AIDS Vaccine Enterprise
$958,333Kevin Osborne · National Institute Of Allergy And Infectious Diseases · Y01 · FY2019 · AI
Global HIV/AIDS Vaccine Enterprise
$958,333National Institute Of Allergy And Infectious Diseases · Y01 · FY2018 · AI
Excellence in Research: Role of the T3SS effector EseN of E. ictaluri in virulence and host immune response.
$958,309Lidiya P Dubytska · Southern University · · FY2021 · BIO
Keeping rural minority 'essential' workplaces open safely during the COVID-19 pandemic: The role of frequent point-of-care molecular workplace surveillance for miners
$958,041Akshay Sood · University Of New Mexico Health Scis Ctr · U01 · FY2021 · GM
A systems immunology approach to evaluate malaria vaccine performance in endemic regions of Kenya
$958,026Ann M Moormann · Univ Of Massachusetts Med Sch Worcester · U01 · FY2025 · AI
Identification of the Initial Targets of Transmission
$958,017Thomas Hope · Northwestern University At Chicago · R01 · FY2015 · AI
NIH Director's Pioneer Award (RMI)
$958,000J. David Gladstone Institutes · DP1 · FY2004 · OD
Recombinant life attenuated vaccine against Argentine hemorrhagic fever
$957,982Slobodan Paessler · University Of Texas Med Br Galveston · R01 · FY2015 · AI
Design and testing of germline-targeting and boosting immunogens to elicit 10E8-like broadly neutralizing antibodies against HIV
$957,981William R Schief · Scripps Research Institute, The · R01 · FY2019 · AI
COMPLETE GENOME SEQUENCING OF BRUCELLA SUIS
$957,964Institute For Genomic Research · U01 · FY2000 · AI
Portable electronically controlled transdermal patch for enfuvirtide delivery
$957,909Maureen L. Mulvihill · Actuated Medical, Inc. · R44 · FY2012 · AI
Novel vaccine against Norovirus
$957,884Xi Jiang · Cincinnati Childrens Hosp Med Ctr · R01 · FY2012 · AI
Automating mosquito microdissection for a malaria PfSPZ vaccine
$957,878Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2023 · AI
Role of inflammation, innate resistance, and immunity in carcinogenesis
$957,864Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA